The current study is a multicentre, randomized, open (unblended), prospective clinical trial which is sponsored by the researchers. The trial is designed to compare the effectiveness between docetaxel plus epirubicin, and docetaxel plus epirubicin plus cyclophosphamide as neoadjuvant chemotherapy for operable premenopausal breast cancer patients, and also to compare the outcomes associated with chemo-induced amenorrhea between the two neoadjuvant chemotherapies. The investigators will randomly assign 600 premenopausal female patients with operable breast cancer to receive four cycles of docetaxel and epirubicin (TE); or four cycles of docetaxel, epirubicin, and cyclophosphamide (TEC). After every two cycles of neoadjuvant chemotherapy, the investigators will estimate the effectiveness of therapy. Patients will undergo modified radical mastectomy or breast-conserving surgery after four cycles of neoadjuvant chemotherapy, and then receive postoperative chemotherapy (two cycles), radiation therapy, ...
The current study is a multicentre, randomized, open (unblended), prospective clinical trial which is sponsored by the researchers. The trial is designed to compare the effectiveness between docetaxel plus epirubicin, and docetaxel plus epirubicin plus cyclophosphamide as neoadjuvant chemotherapy for operable premenopausal breast cancer patients, and also to compare the outcomes associated with chemo-induced amenorrhea between the two neoadjuvant chemotherapies. The investigators will randomly assign 600 premenopausal female patients with operable breast cancer to receive four cycles of docetaxel and epirubicin (TE); or four cycles of docetaxel, epirubicin, and cyclophosphamide (TEC). After every two cycles of neoadjuvant chemotherapy, the investigators will estimate the effectiveness of therapy. Patients will undergo modified radical mastectomy or breast-conserving surgery after four cycles of neoadjuvant chemotherapy, and then receive postoperative chemotherapy (two cycles), radiation therapy, ...
The association between the polymorphism of the angiotensin-converting enzyme (ACE) gene and breast cancer risk has been extensively studied, however , the studies about the prognostic factors and ACE gene polymorphism are limited in number. Our aims were to analyze the distribution of the insertion/deletion (I/D) polymor-phism of the ACE gene in Turkish premenopausal patients with breast cancer, which is more aggressive than the postmenopausal counterpart, and to assess whether DD genotype is associated with poor prognostic factors. The DD genotype has been shown to be associated with the increased serum and tissue levels of ACE, compared to those in II and ID genotypes. ACE genotypes were determined by polymerase chain reaction in 44 Turkish premenopausal patients with breast cancer and in 46 age-matched healthy premenopausal women. ACE genotypes are distributed in patients and control subjects as follows; DD is respectively. In breast cancer patients, no significant association was observed between
Sclerostin is a secreted Wnt antagonist produced almost exclusively by osteocytes that regulates bone mass. However, there is currently limited information on the determinants of sclerostin in a large population-based study. The main objectives of the present study were to: (1) establish reference normative interval values for serum sclerostin in randomly selected healthy premenopausal women; (2) study the changes in serum sclerostin in relation to age in premenopausal and postmenopausal women and the factors that may influence bone turnover; and (3) determine the effect of menopausal status on serum sclerostin. A total of 1803 women were studied (including [n = 1235] premenopausal, and [n = 568] postmenopausal women, respectively, aged 20 to 79 years). A total of 443 healthy premenopausal women (aged 35 to 45 years) were used to establish reference normative intervals for serum sclerostin. All women studied were medically examined and had their bone mineral density values obtained for the ...
Author: Atuegbu Chidiadi Maryann Department: Chemical Pathology Affiliation: Nnamdi Azikiwe University Awka This study evaluated the effect of one month moderate -to-vigorous intensity physical exercise on the ovarian reserve status, ovulatory status and the serum levels of some minerals in premenopausal female university students. Thirty female subjects aged 19-25 years participated in this study and…
Abdominal adiposity is associated with metabolic and hormonal changes, many of which have been associated with the risk of premenopausal breast cancer. In the study to investigate the association between body fat distribution, assessed in 1993 by self-reported waist circumference, hip circumference, and waist to hip ratio, and the incidence of premenopausal breast cancer in the Nurses Health Study II, by the Harvard School of Public Health, posted in PubMed, indicated that during 426,164 person-years of follow-up from 1993 to 2005, 620 cases of breast cancer were diagnosed among 45,799 women. Hormone receptor status information was available for 84% of the breast cancers. The age-standardized incidence rates of breast cancer were 131 per 100,000 person-years among those in the lowest quintile of waist circumference and 136 per 100,000 person-years among those in the highest quintile. No statistically significant associations were found between waist circumference, hip circumference, or the ...
Among Hispanics, young-adult and current body mass index (BMI) were inversely associated with both ER+PR+ and ER−PR− breast cancer. For ER+PR+ disease, risk was substantially reduced among those with elevated BMI throughout adulthood (OR=0.35, 95% CI=0.19-0.62). Height and height-to-waist ratio were positively associated with ER−PR− breast cancer. After adjustment for current BMI, two-fold increased risks were seen for large waist and hip circumferences, regardless of tumor receptor status. Genetic ancestry appeared to modify some of the associations with overall and abdominal adiposity. Among NHWs, findings for overall adiposity were similar to those for Hispanics, but there was no evidence of associations with abdominal adiposity ...
TY - JOUR. T1 - Pre-menopausal and post-menopausal depressed women. AU - Roy, Alec. AU - Linnoila, Markku. AU - Jimerson, David C.. AU - Gold, Philip. AU - Pickar, David. PY - 1986. Y1 - 1986. N2 - In a consecutive series of 28 depressed women, pre-menopausal (n = 13) and post-menopausal (n = 15) patients were compared. Post-menopausal women had significantly higher levels of plasma norepinephrine, plasma 3-methoxy-4-hydroxyphenylglycol, post-dexamethasone plasma cortisol, cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and corticotropin-releasing hormone. However, when biologic measures were adjusted for age by analyses of covariance there were no significant differences. Pre-menopausal women had had significantly more life events before the onset of depression than post-menopausal women. The implications of these findings are discussed.. AB - In a consecutive series of 28 depressed women, pre-menopausal (n = 13) and post-menopausal (n = 15) patients were compared. Post-menopausal women had ...
Nutrition: Calcium and vitamin D cut breast cancer risk in pre-menopausal women. No protective effect was observed in post-menopausal women.
Women who avoid red meat are more likely to be at a healthier weight and have lower levels of chronic inflammation and oxidative stress, according to a study published in the British Journal of Nutrition. Researchers analyzed lifestyle and dietary information in an ethnically diverse group of 275 healthy premenopausal women and collected biomarkers of inflammation linked to cancer incidence.. ...
In summary, our acquiring of quick a single-technology psychological acculturation contributes to a1242156-23-5 growing literature in the evolutionary sciences
Historically, there has been a dearth of information on occupational exposures of women to chemicals and endocrine disruptors and therefore on links between occupational exposures and breast cancer specifically. In November 2012, a landmark paper titled "Breast cancer risk in relation to occupations with exposure to carcinogens and endocrine disruptors: a Canadian case-control study" was published in the journal Environmental Health. In this groundbreaking study the authors showed that across all sectors, women in jobs with potentially high exposures to carcinogens and endocrine disruptors had elevated breast cancer risk and that premenopausal breast cancer risk was highest for automotive plastics and food canning workers. The two key authors of this study, James Brophy, PhD, and Margaret Keith, PhD, will join Jeanne Rizzo, RN, President and CEO of the Breast Cancer Fund and Charlotte Brody, RN, Associate Director, Health Initiatives, BlueGreen Alliance to discuss this study and its implications ...
Among premenopausal women with early stage, HR-positive breast cancer, the addition of ovarian suppression to tamoxifen reduced breast cancer recurrence.
Breastfeeding reduces breast cancer risk among women with a family history of breast cancer, according to a study. Observational studies suggest a relationship between lactation and premenopausal breast cancer risk.
Health,A new study has challenged the ill-effects of obesity as a causative ...Latest research has indicated that having a higher Body Mass Index...The researchers found that a high BMI could result in irregular or...Dr Sarah Cant senior policy and information officer for Breakthro......,Obesity,may,Reduce,Risk,of,Breast,Cancer,in,Pre-menopausal,Women,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
Estrogen inhibition of a key receptor that helps regulate blood pressure may be a new mechanism by which premenopausal women are protected from cardiovascular disease. Abstract The steroid hormone aldosterone (aldo) contributes to cardiovascular disease in animal models and in humans. Aldo activates the mineralocorticoid receptor (MR), a hormone-activated transcription factor, and indeed, pharmacological MR inhibition improves cardiovascular outcomes. Because the incidence of cardiovascular dise
What Your Doctor May Not Tell You About PREmenopause: Balance Your Life and Your Hormones from Thirty to Fifty by John R. Lee, M.D., Jesse Hanley M.D. and Virginia Hopkins
A higher HDL-C level was associated with reduced risk of premenopausal breast cancer. HDL-C ≥ 60 mg/dL decreased breast cancer risk by 0.49-fold (OR, 0.49; 95% CI, 0.33-0.72) compared with HDL-C , 50 mg/dL among premenopausal women. When it was stratified by BMI, however, only in the premenopausal group of BMI , 23.0 kg/m2 was there significant inverse relationship between HDL-C and breast cancer risk (Ptrend , 0.01).. The association between HDL-C and breast cancer risk by menopausal status has been inconsistent among studies (13, 26-33). However, several results show consistent results of our study. In a recent cohort study of 359 cases among 7,575 members, low baseline HDL-C level showed an modest increase of breast cancer only among premenopausal women (hazard ratio, 1.67; 95% CI, 1.06-2.63; ref. 13). In a nested case-control study (33) with 51 incident cases among 5,207 subjects, there was an inverse association between serum HDL-C and breast cancer. The risk was 0.3 (95% CI, 0.1-0.8) for ...
How is breast cancer different in young women than in older women, what unique issues must be faced, and how can you find the support you need?
analog of naturally occurring gonadotropin releasing hormone (GnRH or LHRH.) The analog possesses greater potency than the natural hormone. Lupron acts as a potent inhibitor of gonadotropin secretion when given continuously and in therapeutic doses. Following an initial stimulation, chronic administration of Lupron results in suppression of ovarian steroid production. This effect is reversible upon discontinuation of drug therapy. In humans, subcutaneous administration of single daily doses of Lupron results in an initial increase in circulation levels of LH and FSH, leading to a transient increase in levels of the gonadal steroids estrone and estradiol. However, continuous daily administration of Lupron results in decreased levels of LH and FSH. In premenopausal females, estrogens are reduced to post-menopausal levels. These decreases occur within two to four weeks after initiation of treatment. Lupron produces numerous side effects including cardiovascular symptoms like congestive heart ...
Bupropion smoking side effects penicillin b lactamase does clomid cause breakthrough bleeding amaryl city hotel am kurfürstendamm berlin
Among the many studies that examined breast cancer risk in relation to physical activity, our study is only the second to assess lifetime physical activity in terms of frequency, duration, and intensity of all types of moderate and vigorous activities, including recreational activity, transportation, household and outdoor chores, and occupational activities. We found reduced risks of breast cancer of borderline statistical significance among the most physically active premenopausal (OR = 0.74) and postmenopausal (OR = 0.81) women. When we stratified the study population by age instead of menopausal status, risks were significantly reduced among women under age 50 years (OR = 0.69) and those aged 50 years and older (OR = 0.79). Thus, our study adds to the epidemiological evidence that supports a modest reduction in both pre- and postmenopausal breast cancer risk among physically active women.. Our findings for premenopausal women are in agreement with previous reports from cohort studies (18, 19, ...
Pagani O, Regan MM, Walley BA, Fleming GF, Collecni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Steams V, Bonnefoi HR, Martino S, Geyer Jr CE, Pinotti G, Puglisi F, Crivellari D, Rushtaller T, Winer EP, Rabaglio-Poretti M, Malbach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA, for the TEXT and SOFT Investigators and the International Breast Cancer Study Group. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med 2014;371:107-18. [Ref.ID 97807 ...
Ribociclib combined with hormone therapy significantly improves PFS in premenopausal patients with HR-positive, HER2-negative breast cancer. Learn more!
A new study found physical activity for premenopausal women is very effective in reducing sclerostin a known inhibitor of bone formation and physical training also improves bone health.
Hi I am pre-menopausal and every two or three months my body feels as if I am going to have a period, I get all the symptoms especially the bloated stomach...
Wu and colleagues also take issue with our statement that there was "a median decrease (of Ki67) of 0.13% in the postmenopausal-treated group, whereas in premenopausal women, it increased by 0.19%." Our statement is based on results presented in Table 3, in the last column, where the median between-group differences are shown, with their confidence intervals and P values. For postmenopausal women, this between-group change is −0.13 (-0.42 to 0.08), and for premenopausal women, this difference is +0.19 (-0.46 to 1.07).. Finally, Wu and colleagues note that 89% of the soy group was sampled in the luteal phase, compared with 72% of the placebo group, raising a concern about the legitimacy of comparing the soy and placebo group Ki67 results. We gave significant thought to the presentation of the study findings when it became apparent that luteal phase sampling had not been achieved in all premenopausal women and decided that it would be more appropriate to present intent-to-treat data on all ...
Incontinence affects one in four pre-menopausal women and nearly half of post-menopausal women. But its treatable at any age, and treatment is associated with far less morbidity.
Women who breast-feed their babies even for short periods of time may lower their risk of developing premenopausal breast cancer if they have a family history of the disease in Wilmington. We saw a 59 percent lower risk of breast cancer among women with a family history who had ever breast-fed," stated Dr. Alison Stuebe, lead author of a study appearing in the Aug. 10/24 issue of the Archives of Internal Medicine. "It is surprising to see this really strong association with a pretty decreased risk ...
Women who breast-feed their babies even for short periods of time may lower their risk of developing premenopausal breast cancer if they have a family history of the disease in Camp Lejeune. We saw a 59 percent lower risk of breast cancer among women with a family history who had ever breast-fed," stated Dr. Alison Stuebe, lead author of a study appearing in the Aug. 10/24 issue of the Archives of Internal Medicine. "It is surprising to see this really strong association with a pretty decreased risk ...
i am a 50 yr old pre-menopausal woman with non-tender pitting edema in both shins (not feet, ankles, or legs) worse on the left, very very slight on the rt.. it goes away at night or with elevation. i ...
Schorr M, Fazeli PK, Bachmann KN, Faje AT, Meenaghan E, Kimball A, Singhal V, Ebrahimi S, Gleysteen S, Mickley D, Eddy KT, Misra M, Klibanski A, Miller KK. Differences in Trabecular Plate and Rod Structure in Premenopausal Women Across the Weight Spectrum. J Clin Endocrinol Metab. 2019 10 01; 104(10):4501-4510 ...
The goal of clinical research within IBCSG is to give our patients a longer survival and symptom-free period after primary treatment, and to improve their quality of life.
Aim: This study investigates the prognostic value of cyclin E in relation to tumour growth pattern by analysing stage II primary breast cancers from premenopausal women not subjected to any further adjuvant treatment. In addition, the value of cyclin E as a predictor of tamoxifen response was analysed, by comparing untreated and treated patients with oestrogen receptor positive tumours. Methods: Breast cancer samples, assembled in tissue microarrays, were immunohistochemically stained for cyclin E and evaluated regarding the presence of nuclear staining. The overall growth characteristics of each tumour were assessed using whole tissue sections. Results: Tumours displaying a pushing margin phenotype were strongly associated with high cyclin E levels, lymph node negative disease, a high histological grade, ER negativity, and exhibited a better prognosis compared to tumours with an infiltrative growth pattern. In the total cohort of non-treated patients (N=187), cyclin E was not associated with ...
Background. Higher levels of endogenous sex steroid hormones are associated with increased risks of breast cancer in postmenopausal women. Data for premenopausal women are sparse, in part because of the complexity of measuring hormone levels that vary cyclically. We prospectively evaluated associations between plasma sex hormone levels and breast cancer risk among premenopausal women in a case-control study nested within the Nurses Health Study II. Methods: From 1996 to 1999, blood samples were collected from 18 521 premenopausal women during the early follicular and mid-luteal phases of their menstrual cycles. A total of 197 cases of breast cancer were diagnosed among these women after blood collection and before June 1, 2003; these case subjects were matched to 394 control subjects. Logistic regression models, controlling for breast cancer risk factors, were used to calculate relative risks (RRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. Results: Women in the ...
We have characterized four monoclonal antibodies (mAbs) to the purple ("tartrate-resistant," band 5) acid phosphatase of the human osteoclast (TRAP) and used these to develop a specific serum immunoassay. All four mAbs are of high affinity (Ka = 1-5 x 10(8) L/mol) with a very fast Kassoc (0.2-2.0 x 10(5) L mol-1 s-1) and a moderate Kdissoc (1-3 x 10(-3) s). Two of the mAbs were selected to develop a time-resolved fluorescence immunoassay to measure serum concentrations of TRAP. The mean serum immunoreactive TRAP in a group of healthy premenopausal women and men was 3.7 +/- 1.8 micrograms/L (mean +/- SD) and 3.5 +/- 1.6 micrograms/L, respectively. Significantly higher concentrations of TRAP were found in postmenopausal women (6.3 +/- 2.3 micrograms/L) and in eight patients with Gaucher disease (19.3 +/- 4.7 micrograms/L). Further studies are required to investigate the value of serum TRAP as a marker of bone resorption.. ...
The objective of this study was to conduct an intervention study to test how low-fat yogurt consumption affects postprandial metabolism, chronic inflammation, and intestinal barrier function. Apparently healthy premenopausal women with body mass index (BMI) of 18.5 to 27 (lean) or 30 to 40 kg/m2 (obese) participated in a 9-week controlled intervention study. Participants in each BMI range were randomly assigned to either a low-fat yogurt-supplemented group (Y, yogurt lean; YO, yogurt obese) or a soy pudding-supplemented control group (C, control lean; CO, control obese), with n = 30/group. Participants consumed 12 oz. of yogurt or the control food daily for 9 weeks while maintaining usual caloric intake. At wk 0, 3, 6 and 9, participants provided fasting blood samples for determination of inflammation and endotoxemia, and for weight and blood pressure measurement. At wk 0 and 9, participants consumed 8 oz. of yogurt or the control food, followed by a high-fat, high-carbohydrate challenge meal. Blood
Prior research suggests that several endogenous hormones in premenopausal women are associated with breast cancer risk; however, few studies have evaluated associations of endogenous hormones with mammographic density (MD) in premenopausal women. We conducted a cross-sectional study of plasma hormone levels in relation to MD among 634 cancer-free premenopausal women in the Nurses Health Study II. We measured percent MD from screening mammograms using a computer-assisted method. We assayed estradiol, estrone, and estrone sulfate in blood samples timed in early follicular and mid-luteal phases of the menstrual cycle as well as testosterone, androstenedione, progesterone, dehydroepiandrosterone (DHEA), DHEA sulfate, sex hormone-binding globulin (SHBG), and anti-Müllerian hormone in luteal or untimed samples ...
Prior research suggests that several endogenous hormones in premenopausal women are associated with breast cancer risk; however, few studies have evaluated associations of endogenous hormones with mammographic density (MD) in premenopausal women. We conducted a cross-sectional study of plasma hormone levels in relation to MD among 634 cancer-free premenopausal women in the Nurses Health Study II. We measured percent MD from screening mammograms using a computer-assisted method. We assayed estradiol, estrone, and estrone sulfate in blood samples timed in early follicular and mid-luteal phases of the menstrual cycle as well as testosterone, androstenedione, progesterone, dehydroepiandrosterone (DHEA), DHEA sulfate, sex hormone-binding globulin (SHBG), and anti-Müllerian hormone in luteal or untimed samples ...
Results: Pre- and post-menopausal women had a median age of 35 (31 to 42) and 57 (52 to 68); body mass index 25 (24 to 28) and 27 (23 to 29), CrCl 86 (58 to 112) and 76 (65 to 104) mL/min, respectively. We enrolled 10 African American and 2 white pre-menopausal women; and 5 African American and 1 Hispanic post-menopausal women. After first dose, blood plasma exposure was similar, but genital tract exposure was increased in post-menopausal women resulting in an increased genital tract : blood plasma ratio. At steady state, post-menopausal women had greater exposure in both blood plasma (p = 0.02) and genital tract (p = 0.01), resulting in similar genital tract : blood plasma ratios. C24h was greater in blood plasma (p = 0.04) and genital tract (p = 0.01) in post-menopausal women at steady state. In post-menopausal women, blood plasma AUC and blood plasma C24h exceed standard pharmacokinetic parameters by 160% and 125%, respectively. ...
There was apparently also some research that says that Zometa helped premenopausal breast cancer patients by making it somewhat less likely that cancer would metastasize to the bone. The reports say by 36%, but it had to do with a study of 1800 patients (I think), in which half got Zometa and half didnt (all were premenopausal, early stage breast cancerpatients). 6% of those on Zometa ended up with bone metastases versus 9% of those who didnt get it. 6% of 900 is 54 patients with Zometa, versus 81 patients without Zometa ...
A 2009 systematic review and meta-analysis found that soy consumption by premenopausal females did not affect concentrations of estradiol, estrone, or sex-hormone binding globulin, but did seem to reduce follicle stimulating hormone and luteinizing hormone, and increase the length of menstrual cycles (by an average of just over one day). It was unclear if these changes indicated an estrogenic or anti-estrogenic effect. However, all studies under review were considered at risk for bias. When the numbers were crunched in another way, it appeared that soys seeming effect on follicle stimulating hormone was still significant, but effects on luteinizing hormone and menstrual cycle length were no longer significant. In post-menopausal females, soy consumption did not seem to have any effect on any of these hormones; in peri-menopausal females, much less research had been done but there also did not seem to be significant effects on hormone levels (Hooper ...
Endogenous reproductive hormones and oxidative stress have been independently linked to risk of chronic disease but mostly in postmenopausal women. The interplay between endogenous reproductive hormones and oxidative stress among premenopausal women,
TY - JOUR. T1 - A standardized exercise intervention differentially affects premenopausal and postmenopausal African-American women. AU - Kretzschmar, Jan. AU - Babbitt, Dianne M.. AU - Diaz, Keith M.. AU - Feairheller, Deborah L.. AU - Sturgeon, Kathleen M.. AU - Perkins, Amanda M.. AU - Veerabhadrappa, Praveen. AU - Williamson, Sheara T.. AU - Ling, Chenyi. AU - Lee, Hojun. AU - Grimm, Heather. AU - Thakkar, Sunny R.. AU - Crabbe, Deborah L.. AU - Kashem, Mohammed A.. AU - Brown, Michael D.. PY - 2014/6. Y1 - 2014/6. N2 - OBJECTIVE: African-American women represent an understudied population in menopause research yet face greater postmenopausal challenges associated with mortality than their white peers. We investigated the effects of a mild-intensity aerobic exercise training program on markers of mortality risk in both premenopausal and postmenopausal African-American women. METHODS: Sixteen premenopausal women and 19 postmenopausal women underwent 6 months of mild-intensity aerobic exercise ...
Introduction : Osteoporosis is a systemic skeletal disease characterized by low bone mass and destruction of microarchitecture bone tissue. There are 200 million people with osteoporosis in the world (A Rachman, 2007). Osteoporosis happens in women as much as 90%, whereas in males 41.8% (Puslitbang Gizi Depkes RI tahun 2006). The number of people with osteoporosis in Indonesia is much bigger than the last data Depkes, which pegged the figure of 19.7% of the total population. Purpose : To know the knowledge level and attitude towards osteoporosis and kalsuim intake of premenopausal women in the District of Medan Selayang II. Methods : A cross sectional descriptive study were conducted using questionnaires which are distributed to respondents to collect data. Samples were taken by measure of a non-probability Purposive Sampling technique and has to meet the inclusive and exclusive criterias. The datas were later processed by using the computer with Statistical Package for the Social Sciences ...
The Molecular and Cardiovascular Physiology Lab at is looking at how heart disease risk changes during the menopausal transition and is seeking premenopausal women who are 40 years old or older.. If you have been exercising regularly for the past two years, and do not have cardiovascular disease, you may qualify.. This study will provide you with information on your blood lipid levels, glucose levels, cardiovascular fitness, bone mineral density and body composition. You may also win a $50 gift card to a local business, a gym membership or personal training sessions.. You will be asked to come to campus three times for approximately 1-3 hours per visit. During the visits you will be asked to complete studies of blood vessel health using an ultrasound and Doppler machine and to undergo blood draws at rest and before and after exercise. You will complete a maximal exercise test and an acute bout of exercise.. If interested, email [email protected] or call 413/577-0392.. ...
Menopause is a transition period that may last from several months up to a few years. Misinformation about this topic instills fear in many women as they enter their forties and begin to think about menopause. A good example of this is Western medicines focuses on menopause as a disease that must be treated with . . . Read More ». ...
Foods high in iron list of foods high in iron, and for men and post-menopausal women, for men you will need about 10 milligrams of iron daily, and pre-menopausal women need 15 milligrams. Its not a large number, but it is a very important mineral. Iron is a mineral that is required for the transport … Continue reading. ...
The 40s is a time for big changes, especially women who are in the beginning stages of menopause. There is a myth that a womans facelift results can be affected by the hormonal changes of menopause, making it wise to wait until after this transition has completed. The good news is that there are plenty of facelifts performed on pre-menopausal women that result in long-lasting anti-aging effects. You can plan your facelift surgery on your own terms and leave the internal changes of your body for your primary care physician to worry about.. While the aging effects are not as dramatic or obvious in 40-something patients, the differences made by a facelift surgery can still be meaningful. Patients in this age group, both male and female, can benefit from the changes in their contour and profile. Its a great way to set back the clock before some of the more drastic aging signs have begun to affect the face. Remember that every patient is unique, so your aging process will be yours alone. Consult ...
This article is in response to Jugdaohsingh et al.: The silicon supplement Monomethylsilanetriol is safe and increases the body pool of silicon in healthy Pre-menopausal women. Nutrition & Metabolism 2013 10:37: http://www.nutritionandmetabolism.com/content/10/1/37 The response from the authors is published as Jugdaohsingh et al.: Response to Prof D. Vanden Berghe ...